| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
389,580,000 |
| Market
Cap: |
45.17(B) |
| Last
Volume: |
1,813,692 |
Avg
Vol: |
1,929,144 |
| 52
Week Range: |
$75.49 - $140.45 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 487 |
| Guru Rank Value : 3 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile DexCom is a medical device company primarily focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems. Co.'s product candidates include Dexcom G7®, which is designed with the goal of carrying forward many of the same features as Co.'s G6 CGM system and adding several new or improved features. Co.'s products include: DexCom G6® integrated Continuous Glucose Monitoring System (G6), which is a type of CGM system to be used as part of an integrated system with other medical devices and electronic interfaces; and DexCom Share®, which transmit glucose information to the cloud and then to apps on the mobile devices of up to five designated recipients.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
64,005 |
267,979 |
302,595 |
574,627 |
| Total Sell Value |
$8,769,441 |
$35,482,928 |
$39,449,301 |
$69,910,840 |
| Total People Sold |
6 |
8 |
13 |
15 |
| Total Sell Transactions |
10 |
24 |
47 |
82 |
| End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Doubleday Richard |
EVP Chief Commercial Officer |
• – – |
2019-09-09 |
4 |
S |
$145.38 |
$875,594 |
D/D |
(5,843) |
66,821 |
|
- |
|
| Pacelli Steven Robert |
EVP Strategy and Corporate Dev |
• – – |
2019-09-09 |
4 |
S |
$145.46 |
$875,620 |
D/D |
(5,843) |
83,815 |
|
- |
|
| Sayer Kevin R |
President, CEO and Chairman |
• • – |
2019-09-09 |
4 |
S |
$145.47 |
$2,146,269 |
D/D |
(14,322) |
232,937 |
|
- |
|
| Balo Andrew K |
* |
• – – |
2019-09-03 |
4 |
AS |
$170.00 |
$6,290 |
D/D |
(37) |
69,409 |
|
- |
|
| Sayer Kevin R |
President, CEO and Chairman |
• • – |
2019-09-03 |
4 |
AS |
$169.98 |
$1,701,274 |
D/D |
(10,000) |
247,259 |
|
- |
|
| Ace Heather S |
SVP Human Resources |
• – – |
2019-08-23 |
4 |
AS |
$174.59 |
$1,266,062 |
D/D |
(7,243) |
59,091 |
|
- |
|
| Doubleday Richard |
EVP Chief Commercial Officer |
• – – |
2019-08-23 |
4 |
AS |
$174.56 |
$353,088 |
I/I |
(2,016) |
2,016 |
|
- |
|
| Sayer Kevin R |
President, CEO and Chairman |
• • – |
2019-08-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
20,841 |
257,259 |
|
- |
|
| Sayer Kevin R |
President, CEO and Chairman |
• • – |
2019-08-15 |
4 |
AS |
$154.53 |
$1,561,167 |
D/D |
(10,000) |
278,100 |
|
- |
|
| Doubleday Richard |
EVP Chief Commercial Officer |
• – – |
2019-07-23 |
4 |
AS |
$152.29 |
$309,570 |
I/I |
(2,016) |
4,032 |
|
- |
|
| Sayer Kevin R |
President, CEO and Chairman |
• • – |
2019-07-08 |
4 |
AS |
$145.32 |
$877,476 |
D/D |
(6,000) |
288,100 |
|
- |
|
| Altman Steven R |
Director |
– • – |
2019-07-01 |
4 |
AS |
$151.62 |
$379,052 |
I/I |
(2,500) |
51,304 |
|
- |
|
| Doubleday Richard |
EVP Chief Commercial Officer |
• – – |
2019-06-24 |
4 |
AS |
$149.00 |
$301,626 |
I/I |
(2,016) |
6,048 |
|
- |
|
| Pacelli Steven Robert |
EVP Strategy and Corporate Dev |
• – – |
2019-06-24 |
4 |
AS |
$148.85 |
$466,304 |
D/D |
(3,116) |
89,658 |
|
- |
|
| Augustinos Nicholas |
Director |
– • – |
2019-06-14 |
4 |
AS |
$146.32 |
$176,755 |
D/D |
(1,208) |
9,270 |
|
- |
|
| Leach Jacob Steven |
EVP Chief Technology Officer |
• – – |
2019-06-13 |
4 |
AS |
$145.19 |
$741,008 |
D/D |
(5,099) |
115,781 |
|
- |
|
| Sayer Kevin R |
President, CEO and Chairman |
• • – |
2019-06-10 |
4 |
AS |
$127.01 |
$796,444 |
D/D |
(6,000) |
294,100 |
|
- |
|
| Murphy Patrick Michael |
SVP Legal Affairs |
• – – |
2019-06-10 |
4 |
AS |
$127.03 |
$50,812 |
D/D |
(400) |
35,460 |
|
- |
|
| Balo Andrew K |
* |
• – – |
2019-06-05 |
4 |
AS |
$125.00 |
$978,125 |
D/D |
(7,825) |
69,392 |
|
- |
|
| Abbey Donald |
EVP Quality and Regulatory Aff |
• – – |
2019-06-03 |
4 |
S |
$121.08 |
$1,093,352 |
D/D |
(9,030) |
86,393 |
|
- |
|
| Foletta Mark G |
Director |
– • – |
2019-05-31 |
4 |
A |
$0.00 |
$3 |
D/D |
3,055 |
3,055 |
|
- |
|
| Altman Steven R |
Director |
– • – |
2019-05-31 |
4 |
A |
$0.00 |
$3 |
D/D |
2,676 |
2,676 |
|
- |
|
| Augustinos Nicholas |
Director |
– • – |
2019-05-31 |
4 |
A |
$0.00 |
$3 |
D/D |
2,676 |
10,478 |
|
- |
|
| Topol Eric |
Director |
– • – |
2019-05-31 |
4 |
A |
$0.00 |
$3 |
D/D |
2,766 |
2,766 |
|
- |
|
| Kahn Barbara |
Director |
– • – |
2019-05-31 |
4 |
A |
$0.00 |
$3 |
D/D |
2,613 |
2,613 |
|
- |
|
2306 Records found
|
|
Page 25 of 93 |
|
|
2.14 (1.88%) 
